BACKGROUND: Severe hyperbilirubinemia can cause permanent neurological damage in particular in neonates, whereas mildly elevated serum bilirubin protects from various oxidative stress-mediated diseases. The present work aimed to establish the intracellular unconjugated bilirubin concentrations (iUCB) thresholds differentiating between anti- and pro-oxidant effects. METHODS: Hepatic (HepG2), heart endothelial (H5V), kidney tubular (HK2) and neuronal (SH-SY5Y) cell lines were exposed to increasing concentration of bilirubin. iUCB, cytotoxicity, intracellular reactive oxygen species (ROS) concentrations, and antioxidant capacity (50% efficacy concentration (EC50)) were determined. RESULTS: Exposure of SH-SY5Y to UCB concentration > 3.6 µM (iUCB of 25 ng/mg) and >15 µM in H5V and HK2 cells (iUCB of 40 ng/mg) increased intracellular ROS production (p < 0.05). EC50 of the antioxidant activity was 21 µM (iUCB between 5.4 and 21 ng/mg) in HepG2 cells, 0.68 µM (iUCB between 3.3 and 7.5 ng/mg) in SH-SY5Y cells, 2.4 µM (iUCB between 3 and 6.7 ng/mg) in HK2 cells, and 4 µM (iUCB between 4.7 and 7.5 ng/mg) in H5V cells. CONCLUSIONS: In all the cell lines studied, iUCB of around 7 ng/mg protein had antioxidant activities, while iUCB > 25 ng/mg protein resulted in a prooxidant and cytotoxic effects. UCB metabolism was found to be cell-specific resulting in different iUCB.

4th Department of Internal Medicine Faculty General Hospital and 1st Faculty of Medicine Charles University 121 08 Prague 2 Czech Republic

AOP MH2F Team LAAS CNRS 7 avenue de l'Europe 31400 Toulouse France

Department of Life Sciences University of Trieste 34127 Trieste Italy

Institute of Medical Biochemistry and Laboratory Diagnostics Faculty General Hospital and 1st Faculty of Medicine Charles University 121 08 Prague 2 Czech Republic

Italian Liver Foundation Bldg Q AREA Science Park Basovizza SS14 Km 163 5 34149 Trieste Italy

Zobrazit více v PubMed

Ahlfors C.E., Wennberg R.P., Ostrow J.D., Tiribelli C. Unbound (free) bilirubin: Improving the paradigm for evaluating neonatal jaundice. Clin. Chem. 2009;55:1288–1299. doi: 10.1373/clinchem.2008.121269. PubMed DOI

Zucker S.D., Goessling W., Hoppin A.G. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J. Biol. Chem. 1999;274:10852–10862. doi: 10.1074/jbc.274.16.10852. PubMed DOI

Zelenka J., Lenícek M., Muchová L., Jirsa M., Kudla M., Balaz P., Zadinová M., Ostrow J.D., Wong R.J., Vítek L. Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 2008;867:37–42. doi: 10.1016/j.jchromb.2008.03.005. PubMed DOI

Kapitulnik J., Gonzalez F.J. Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Mol. Pharmacol. 1993;43:722–725. PubMed

De Matteis F., Lord G.A., Kee Lim C., Pons N. Bilirubin degradation by uncoupled cytochrome P450. Comparison with a chemical oxidation system and characterization of the products by high-performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. RCM. 2006;20:1209–1217. doi: 10.1002/rcm.2431. PubMed DOI

Coles B.F., Kadlubar F.F. Human Alpha Class Glutathione S-Transferases: Genetic Polymorphism, Expression, and Susceptibility to Disease. In: Sies H., Packer L., editors. Methods in Enzymology. Volume 401. Academic Press; Cambridge, MA, USA: 2005. pp. 9–42. Gluthione Transferases and Gamma-Glutamyl Transpeptidases. PubMed

Nakamura A., Nakajima M., Yamanaka H., Fujiwara R., Yokoi T. Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab. Dispos. Biol. Fate Chem. 2008;36:1461–1464. doi: 10.1124/dmd.108.021428. PubMed DOI

Schinkel A.H. The physiological function of drug-transporting P-glycoproteins. Semin. Cancer Biol. 1997;8:161–170. doi: 10.1006/scbi.1997.0068. PubMed DOI

Falcão A.S., Bellarosa C., Fernandes A., Brito M.A., Silva R.F.M., Tiribelli C., Brites D. Role of multidrug resistance-associated protein 1 expression in the in vitro susceptibility of rat nerve cell to unconjugated bilirubin. Neuroscience. 2007;144:878–888. doi: 10.1016/j.neuroscience.2006.10.026. PubMed DOI

Corich L., Aranda A., Carrassa L., Bellarosa C., Ostrow J.D., Tiribelli C. The cytotoxic effect of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells is modulated by the expression level of MRP1 but not MDR1. Biochem. J. 2009;417:305–312. doi: 10.1042/BJ20080918. PubMed DOI

Rigato I., Pascolo L., Fernetti C., Ostrow J.D., Tiribelli C. The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin. Biochem. J. 2004;383:335–341. doi: 10.1042/BJ20040599. PubMed DOI PMC

Calligaris S., Cekic D., Roca-Burgos L., Gerin F., Mazzone G., Ostrow J.D., Tiribelli C. Multidrug resistance associated protein 1 protects against bilirubin-induced cytotoxicity. FEBS Lett. 2006;580:1355–1359. doi: 10.1016/j.febslet.2006.01.056. PubMed DOI

Scheffer G.L., Kool M., de Haas M., de Vree J.M.L., Pijnenborg A.C.L.M., Bosman D.K., Elferink R.P.J.O., van der Valk P., Borst P., Scheper R.J. Tissue distribution and induction of human multidrug resistant protein 3. Lab. Investig. J. Tech. Methods Pathol. 2002;82:193–201. doi: 10.1038/labinvest.3780411. PubMed DOI

Bellarosa C., Bortolussi G., Tiribelli C. The role of ABC transporters in protecting cells from bilirubin toxicity. Curr. Pharm. Des. 2009;15:2884–2892. doi: 10.2174/138161209789058246. PubMed DOI

Watchko J.F., Tiribelli C. Bilirubin-induced neurologic damage. N. Engl. J. Med. 2014;370:979. doi: 10.1056/NEJMc1315973. PubMed DOI

Bosma P.J., Chowdhury J.R., Bakker C., Gantla S., de Boer A., Oostra B.A., Lindhout D., Tytgat G.N., Jansen P.L., Oude Elferink R.P. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N. Engl. J. Med. 1995;333:1171–1175. doi: 10.1056/NEJM199511023331802. PubMed DOI

Vítek L. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front. Pharmacol. 2012;3:55. doi: 10.3389/fphar.2012.00055. PubMed DOI PMC

Baranano D.E., Rao M., Ferris C.D., Snyder S.H. Biliverdin reductase: A major physiologic cytoprotectant. Proc. Natl. Acad. Sci. USA. 2002;99:16093–16098. doi: 10.1073/pnas.252626999. PubMed DOI PMC

Gopinathan V., Miller N.J., Milner A.D., Rice-Evans C.A. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett. 1994;349:197–200. doi: 10.1016/0014-5793(94)00666-0. PubMed DOI

Farrera J.A., Jaumà A., Ribó J.M., Peiré M.A., Parellada P.P., Roques-Choua S., Bienvenue E., Seta P. The antioxidant role of bile pigments evaluated by chemical tests. Bioorg. Med. Chem. 1994;2:181–185. doi: 10.1016/S0968-0896(00)82013-1. PubMed DOI

Doré S., Snyder S.H. Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann. N. Y. Acad. Sci. 1999;890:167–172. doi: 10.1111/j.1749-6632.1999.tb07991.x. PubMed DOI

Liu Y., Zhu B., Wang X., Luo L., Li P., Paty D.W., Cynader M.S. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: Implications for the role of oxidative stress in the development of multiple sclerosis. J. Neuroimmunol. 2003;139:27–35. doi: 10.1016/S0165-5728(03)00132-2. PubMed DOI

Gazzin S., Strazielle N., Tiribelli C., Ghersi-Egea J.-F. Transport and Metabolism at Blood–Brain Interfaces and in Neural Cells: Relevance to Bilirubin-Induced Encephalopathy. Front. Pharmacol. 2012;3 doi: 10.3389/fphar.2012.00089. PubMed DOI PMC

Derick S., Gironde C., Perio P., Reybier K., Nepveu F., Jauneau A., Furger C. LUCS (Light-Up Cell System), a universal high throughput assay for homeostasis evaluation in live cells. Sci. Rep. 2017;7:18069. doi: 10.1038/s41598-017-18211-2. PubMed DOI PMC

Gironde C., Rigal M., Dufour C., Furger C. AOP1, a New Live Cell Assay for the Direct and Quantitative Measure of Intracellular Antioxidant Effects. Antioxid. Basel Switz. 2020;9:471. doi: 10.3390/antiox9060471. PubMed DOI PMC

Vitek L., Bellarosa C., Tiribelli C. Induction of Mild Hyperbilirubinemia: Hype or Real Therapeutic Opportunity? Clin. Pharmacol. Ther. 2018 doi: 10.1002/cpt.1341. PubMed DOI

Mirabelli P., Coppola L., Salvatore M. Cancer Cell Lines Are Useful Model Systems for Medical Research. Cancers. 2019;11:1098. doi: 10.3390/cancers11081098. PubMed DOI PMC

Keppler D. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab. Dispos. Biol. Fate Chem. 2014;42:561–565. doi: 10.1124/dmd.113.055772. PubMed DOI

Iusuf D., van de Steeg E., Schinkel A.H. Hepatocyte hopping of OATP1B substrates contributes to efficient hepatic detoxification. Clin. Pharmacol. Ther. 2012;92:559–562. doi: 10.1038/clpt.2012.143. PubMed DOI

Abu-Bakar A., Arthur D.M., Wikman A.S., Rahnasto M., Juvonen R.O., Vepsäläinen J., Raunio H., Ng J.C., Lang M.A. Metabolism of bilirubin by human cytochrome P450 2A6. Toxicol. Appl. Pharmacol. 2012;261:50–58. doi: 10.1016/j.taap.2012.03.010. PubMed DOI

Brites D. Bilirubin injury to neurons and glial cells: New players, novel targets, and newer insights. Semin. Perinatol. 2011;35:114–120. doi: 10.1053/j.semperi.2011.02.004. PubMed DOI

Jenkinson S.E., Chung G.W., van Loon E., Bakar N.S., Dalzell A.M., Brown C.D.A. The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule. Pflugers Arch. 2012;464:601–611. doi: 10.1007/s00424-012-1163-2. PubMed DOI

Ngai K.-C., Yeung C.-Y., Leung C.-S. Difference in susceptibilities of different cell lines to bilirubin damage. J. Paediatr. Child Health. 2000;36:51–55. doi: 10.1046/j.1440-1754.2000.00436.x. PubMed DOI

Ollinger R., Bilban M., Erat A., Froio A., McDaid J., Tyagi S., Csizmadia E., Graça-Souza A.V., Liloia A., Soares M.P., et al. Bilirubin: A natural inhibitor of vascular smooth muscle cell proliferation. Circulation. 2005;112:1030–1039. doi: 10.1161/CIRCULATIONAHA.104.528802. PubMed DOI

Chan G.K.Y., Kleinheinz T.L., Peterson D., Moffat J.G. A Simple High-Content Cell Cycle Assay Reveals Frequent Discrepancies between Cell Number and ATP and MTS Proliferation Assays. PLoS ONE. 2013;8:e63583. doi: 10.1371/journal.pone.0063583. PubMed DOI PMC

Tell G., Gustincich S. Redox state, oxidative stress, and molecular mechanisms of protective and toxic effects of bilirubin on cells. Curr. Pharm. Des. 2009;15:2908–2914. doi: 10.2174/138161209789058174. PubMed DOI

Brito M.A., Lima S., Fernandes A., Falcão A.S., Silva R.F.M., Butterfield D.A., Brites D. Bilirubin injury to neurons: Contribution of oxidative stress and rescue by glycoursodeoxycholic acid. Neurotoxicology. 2008;29:259–269. doi: 10.1016/j.neuro.2007.11.002. PubMed DOI

Kumar S., Guha M., Choubey V., Maity P., Srivastava K., Puri S.K., Bandyopadhyay U. Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species. Free Radic. Biol. Med. 2008;44:602–613. doi: 10.1016/j.freeradbiomed.2007.10.057. PubMed DOI

Oakes G.H., Bend J.R. Early steps in bilirubin-mediated apoptosis in murine hepatoma (Hepa 1c1c7) cells are characterized by aryl hydrocarbon receptor-independent oxidative stress and activation of the mitochondrial pathway. J. Biochem. Mol. Toxicol. 2005;19:244–255. doi: 10.1002/jbt.20086. PubMed DOI

Hopkins P.N., Wu L.L., Hunt S.C., James B.C., Vincent G.M., Williams R.R. Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease. Arterioscler. Thromb. Vasc. Biol. 1996;16:250–255. doi: 10.1161/01.ATV.16.2.250. PubMed DOI

Oh S.W., Lee E.S., Kim S., Na K.Y., Chae D.W., Kim S., Chin H.J. Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis. BMC Nephrol. 2013;14:105. doi: 10.1186/1471-2369-14-105. PubMed DOI PMC

Fujii M., Inoguchi T., Sasaki S., Maeda Y., Zheng J., Kobayashi K., Takayanagi R. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney Int. 2010;78:905–919. doi: 10.1038/ki.2010.265. PubMed DOI

Marilena G. New physiological importance of two classic residual products: Carbon monoxide and bilirubin. Biochem. Mol. Med. 1997;61:136–142. doi: 10.1006/bmme.1997.2610. PubMed DOI

Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043–1046. doi: 10.1126/science.3029864. PubMed DOI

Stocker R., Glazer A.N., Ames B.N. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA. 1987;84:5918–5922. doi: 10.1073/pnas.84.16.5918. PubMed DOI PMC

Wu T.-W., Carey D., Wu J., Sugiyama H. The cytoprotective effects of bilirubin and biliverdin on rat hepatocytes and human erythrocytes and the impact of albumin. Biochem. Cell Biol. 1991;69:828–834. doi: 10.1139/o91-123. PubMed DOI

Giraudi P.J., Bellarosa C., Coda-Zabetta C.D., Peruzzo P., Tiribelli C. Functional induction of the cystine-glutamate exchanger system Xc(-) activity in SH-SY5Y cells by unconjugated bilirubin. PLoS ONE. 2011;6:e29078. doi: 10.1371/journal.pone.0029078. PubMed DOI PMC

He L., He T., Farrar S., Ji L., Liu T., Ma X. Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species. Cell. Physiol. Biochem. 2017;44:532–553. doi: 10.1159/000485089. PubMed DOI

McDonagh A.F., Assisi F. The ready isomerization of bilirubin IX- in aqueous solution. Biochem. J. 1972;129:797–800. doi: 10.1042/bj1290797. PubMed DOI PMC

Jašprová J., Dvořák A., Vecka M., Leníček M., Lacina O., Valášková P., Zapadlo M., Plavka R., Klán P., Vítek L. A novel accurate LC-MS/MS method for quantitative determination of Z-lumirubin. Sci. Rep. 2020;10:4411. doi: 10.1038/s41598-020-61280-z. PubMed DOI PMC

Nieminen A.-L., Gores G.J., Bond J.M., Imberti R., Herman B., Lemasters J.J. A novel cytotoxicity screening assay using a multiwell fluorescence scanner. Toxicol. Appl. Pharmacol. 1992;115:147–155. doi: 10.1016/0041-008X(92)90317-L. PubMed DOI

Dengler W.A., Schulte J., Berger D.P., Mertelsmann R., Fiebig H.H. Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anticancer Drugs. 1995;6:522–532. doi: 10.1097/00001813-199508000-00005. PubMed DOI

Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4. PubMed DOI

Ewing J.F., Janero D.R. Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal. Biochem. 1995;232:243–248. doi: 10.1006/abio.1995.0014. PubMed DOI